市場調査レポート
商品コード
1754838

臨床意思決定支援システムの世界市場:2034年までの機会と戦略

Clinical Decision Support System Global Market Opportunities And Strategies To 2034


出版日
ページ情報
英文 333 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.80円
臨床意思決定支援システムの世界市場:2034年までの機会と戦略
出版日: 2025年06月16日
発行: The Business Research Company
ページ情報: 英文 333 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の臨床意思決定支援システム市場は、2019年に16億8,493万米ドルと評価され、2024年まで13.00%以上のCAGRで成長しました。

個別化医療に対する需要の高まり

実績期間中、個別化医療に対する需要の高まりが臨床意思決定支援システム市場の成長を支えました。個別化医療はゲノムデータを活用して治療をカスタマイズするもので、臨床意思決定支援システム(CDSS)は遺伝子検査結果と臨床ガイドラインを統合することでこれを強化します。AI主導のCDSSは患者データを分析して治療反応を予測し、医師が最も効果的な治療法を選択できるようにします。このデータ主導型のアプローチは精度を向上させ、治療が標準化されるのではなく個別化されることを保証します。例えば、2022年10月、米国を拠点とし、科学者、患者、医療提供者を代表する組織である個別化医療連合(Personalized Medicine Coalition)は、患者とヘルスケアシステムに利益をもたらす個別化医療の理解と導入を促進するため、複数のタイプのがん、遺伝的希少疾患、さまざまな慢性疾患や感染症の患者向けに、75,000以上の遺伝子検査製品と300以上の個別化医薬品が市場に出回っていると推定しています。さらに、個別化医療を提唱する米国の個別化医療連合(PMC)によると、2022年には米国食品医薬品局による新薬承認の34%を個別化医薬品が占めるようになり、過去8年間はいずれも承認の25%以上を個別化医薬品が占めています。したがって、個別化医療に対する需要の高まりが、臨床意思決定支援システム市場の成長を牽引しました。

目次

第1章 エグゼクティブサマリー

  • 臨床意思決定支援システム-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 臨床意思決定支援システム市場の定義とセグメンテーション
  • 市場セグメンテーション:コンポーネント別
    • サービス
    • ソフトウェア
    • ハードウェア
  • 市場セグメンテーション:モデル別
    • 知識ベースCDSS
    • 非知識ベースCDSS
  • 市場セグメンテーション:提供モード別
    • オンプレミス
    • クラウドベース
  • 市場セグメンテーション:用途別
    • 医療診断
    • アラートとリマインダー
    • 処方決定サポート
    • 情報検索
    • 臨床実践ガイドライン
    • その他の用途
  • 市場セグメンテーション:エンドユーザー別
    • クリニック
    • 病院
    • 外来手術センター
    • 一般開業医
    • 精神科医
    • その他のエンドユーザー

第7章 主要な市場動向

  • 臨床意思決定支援システムの革新を推進する戦略的パートナーシップ
  • 臨床意思決定支援システムへの生成AIの統合
  • AI主導の臨床インテリジェンスでヘルスケア従事者を支援
  • デジタルCDSイノベーションによる心血管ケアの最適化
  • 個別化インスリン投与のためのクラウドベースの臨床意思決定支援の進歩
  • AIを活用した診断でモバイル臨床意思決定支援を強化

第8章 世界臨床意思決定支援システムの成長分析と戦略分析フレームワーク

  • 世界: PESTEL分析
    • 政治的
    • 経済
    • 社会
    • 技術的
    • 環境
    • 法律上
  • エンドユーザー分析(B2B)
    • クリニック
    • 病院
    • 外来手術センター
    • その他のエンドユーザー
  • 世界の臨床意思決定支援システム市場の成長率分析
  • 市場成長実績, 2019-2024
    • 市場促進要因2019年~2024年
    • 市場抑制要因2019年-2024年
  • 市場成長予測, 2024-2029, 2034F
    • 市場促進要因2024年~2029年
    • 市場抑制要因2024年~2029年
  • 成長予測の貢献要因
    • 量的成長の貢献者
    • 促進要因
    • 抑制要因
  • 世界の臨床意思決定支援システムの総アドレス可能市場(TAM)

第9章 世界の臨床意思決定支援システム市場セグメンテーション

  • 世界の臨床意思決定支援システム市場:コンポーネント別、実績と予測, 2019-2024, 2029F, 2034F
  • 世界の臨床意思決定支援システム市場:モデル別、実績と予測, 2019-2024, 2029F, 2034F
  • 世界の臨床意思決定支援システム市場:提供モード別、実績と予測, 2019-2024, 2029F, 2034F
  • 世界の臨床意思決定支援システム市場:用途別、実績と予測, 2019-2024, 2029F, 2034F
  • 世界の臨床意思決定支援システム市場、エンドユーザー別、実績と予測, 2019-2024, 2029F, 2034F
  • 世界の臨床意思決定支援システム市場、サービス、タイプ別サブセグメンテーション:実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の臨床意思決定支援システム市場、ソフトウェア、タイプ別サブセグメンテーション:実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の臨床意思決定支援システム市場、ハードウェア、タイプ別サブセグメンテーション:実績と予測, 2019-2024, 2024-2029F, 2034F

第10章 臨床意思決定支援システム市場、地域別・国別分析

  • 世界の臨床意思決定支援システム市場(地域別)、実績と予測, 2019-2024, 2029F, 2034F
  • 世界の臨床意思決定支援システム市場(国別)、実績と予測, 2019-2024, 2029F, 2034F

第11章 アジア太平洋市場

第12章 西欧市場

第13章 東欧市場

第14章 北米市場

第15章 南米市場

第16章 中東市場

第17章 アフリカ市場

第18章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Epic Systems Corporation
  • Oracle Corporation
  • Medical Information Technology, Inc.(Meditech)
  • UnitedHealth Group.(Change Healthcare Inc.)
  • Athenahealth Inc.

第19章 その他の大手企業と革新的企業

  • Siemens Healthineers GmbH
  • Wolters Kluwer N.V.
  • Altera Digital Health
  • MEDHOST
  • TruBridge
  • McKesson Corporation
  • Koninklijke Philips N.V.(Royal Philips)
  • International Business Machines Corporation(IBM Watson Health)
  • GE Healthcare Technologies, Inc.
  • Allscripts Healthcare Solutions Inc.
  • Zynx Health Inc.
  • Carestream Health Inc
  • NextGen Healthcare Inc.
  • Agfa-Gevaert N.V.(Agfa)
  • VisualDx

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • AirStrip Technologies Acquired DECISIO Health
  • VitalHub Acquired MedCurrent Corporation
  • Beckman Coulter Diagnostics Acquired StoCastic
  • Dedalus Group Acquired ExpertDoc
  • Amalgam Acquired Avhana Health

第23章 臨床意思決定支援システム市場における最近の動向

第24章 機会と戦略

  • 2029年の世界臨床意思決定支援システム市場- 最も新たな機会を提供する国
  • 2029年の世界臨床意思決定支援システム市場- 最も新たな機会を提供するセグメント
  • 2029年の世界臨床意思決定支援システム市場- 成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 臨床意思決定支援システム市場、結論・提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1647

Clinical decision support systems (CDSS) are computer-based tools designed to assist healthcare professionals in making informed clinical decisions by analyzing patient data and providing evidence-based recommendations. These systems are utilized by a wide range of healthcare providers, including physicians, nurses, and allied health professionals, to enhance patient care across various medical settings.

The clinical decision support systems market consists of revenues generated by entities (organizations, sole traders, and partnerships) involved in the development and implementation of these systems. Clinical decision support systems (CDSS) are computer-based programs designed to enhance healthcare delivery by providing clinicians with evidence-based knowledge and patient-specific information at the point of care.

The global clinical decision support systems market was valued at $1,684.93 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 13.00%.

Rising Demand For Personalized Medicine

During the historic period, the rising demand for personalized medicine supported the growth of the clinical decision support systems market. Personalized medicine utilizes genomic data to tailor treatments, and clinical decision support systems (CDSS) enhance this by integrating genetic test results with clinical guidelines. AI-driven CDSS analyzes patient data to predict treatment responses, enabling physicians to select the most effective therapies. This data-driven approach improves precision, ensuring treatments are personalized rather than standardized. For example, in October 2022, the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system, estimated that more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, in 2022, according to the Personalized Medicine Coalition (PMC), a US-based company that advocates for personalized medicine, personalized medicines will account for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, the rising demand for personalized medicine drove the growth of the clinical decision support systems market.

Strategic Partnerships Driving Innovation In Clinical Decision Support Systems

Major companies operating in the clinical decision support systems market are adopting a strategic partnerships approach to develop advanced clinical solutions. Strategic partnerships help clinical decision support systems companies by combining resources and expertise, enhancing research and development capabilities, expanding market reach, and accelerating commercialization, ultimately driving innovation and growth in the clinical decision support systems industry. For instance, in October 2024, Nordic Consulting Partners, Inc., a US-based healthcare consulting firm specializing in EHR implementation, partnered with BeeKeeperAI, Inc., a US-based healthcare AI company focused on privacy-preserving AI solutions to accelerate AI-driven clinical decision support at the point of care by enabling secure, privacy-preserving access to real-world healthcare data. This collaboration leverages BeeKeeperAI's confidential computing technology and Nordic's deep expertise in healthcare IT and EHR integration to facilitate the development and deployment of AI models without compromising patient privacy. The partnership aims to enhance clinical workflows, improve diagnostic accuracy, and drive better patient outcomes while ensuring compliance with stringent data security regulations.

The global clinical decision support systems market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 76.23% of the total market in 2023.

Clinical Decision Support System Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global clinical decision support System market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for clinical decision support clinical decision support? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The clinical decision support market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider clinical decision support system market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by component, by model, by delivery mode, by application and by end-user.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by component, by model, by delivery mode, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations This section includes recommendations for clinical decision support system providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Component: Services; Software; Hardware
  • 2) By Model: Knowledge-Based CDSS; Non-Knowledge-Based CDSS
  • 3) By Delivery Mode: On-Permise; Cloud-Based
  • 4) By Application: Medical Diagnosis; Alerts And Reminders; Prescription Decision Support; Information Retrieval; Clinical Practice Guidelines; Other Applications
  • 5) By End-User: Clinics; Hospitals; Ambulatory Surgical Centers; General Practitioners; Psychiatrists; Other End Users
  • Companies Mentioned: Epic Systems Corporation; Oracle Corporation; Medical Information Technology, Inc. (Meditech); UnitedHealth Group. (Change Healthcare Inc.); Athenahealth Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; clinical decision support system indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Clinical Decision Support Systems - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Clinical Decision Support Systems Market Definition And Segmentations
  • 6.4 Market Segmentation By Component
    • 6.4.1 Services
    • 6.4.2 Software
    • 6.4.3 Hardware
  • 6.5 Market Segmentation By Model
    • 6.5.1 Knowledge-Based CDSS
    • 6.5.2 Non-Knowledge-Based CDSS
  • 6.6 Market Segmentation By Delivery Mode
    • 6.6.1 On-Premise
    • 6.6.2 Cloud-Based
  • 6.7 Market Segmentation By Application
    • 6.7.1 Medical Diagnosis
    • 6.7.2 Alerts and Reminders
    • 6.7.3 Prescription Decision Support
    • 6.7.4 Information Retrieval
    • 6.7.5 Clinical Practice Guidelines
    • 6.7.6 Other Applications
  • 6.8 Market Segmentation By End-User
    • 6.8.1 Clinics
    • 6.8.2 Hospitals
    • 6.8.3 Ambulatory Surgical Centers
    • 6.8.4 General Practitioners
    • 6.8.5 Psychiatrists
    • 6.8.6 Other End Users

7 Major Market Trends

  • 7.1 Strategic Partnerships Driving Innovation In Clinical Decision Support Systems
  • 7.2 Integration Of Generative AI In Clinical Decision Support Systems
  • 7.3 Empowering Healthcare Professionals With AI-Driven Clinical Intelligence
  • 7.4 Optimizing Cardiovascular Care With Digital CDS Innovations
  • 7.5 Advancements In Cloud-Based Clinical Decision Support For Personalized Insulin Dosing
  • 7.6 AI-Powered Diagnostics Enhancing Mobile Clinical Decision Support

8 Global Clinical Decision Support Systems Growth Analysis And Strategic Analysis Framework

  • 8.1 Global: PESTEL Analysis
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End Users (B2B)
    • 8.2.1 Clinics
    • 8.2.2 Hospitals
    • 8.2.3 Ambulatory Surgical Centers
    • 8.2.4 Other End Users
  • 8.3 Global Clinical Decision Support Systems Market Growth Rate Analysis
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
    • 8.5.1 Market Drivers 2024 - 2029
    • 8.5.2 Market Restraints 2024 - 2029
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global Clinical Decision Support Systems Total Addressable Market (TAM)

9 Global Clinical Decision Support Systems Market Segmentation

  • 9.1 Global Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Clinical Decision Support Systems Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Clinical Decision Support Systems Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Clinical Decision Support Systems Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million)
  • 9.7 Global Clinical Decision Support Systems Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million)
  • 9.8 Global Clinical Decision Support Systems Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million)

10 Clinical Decision Support Systems Market, Regional and Country Analysis

  • 10.1 Global Clinical Decision Support Systems Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global Clinical Decision Support Systems Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia Pacific Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia Pacific Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia Pacific Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Clinical Decision Support Systems Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Investments
    • 11.9.11 Major Companies
  • 11.10 China Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Investments
    • 11.19.11 Major Companies
  • 11.20 Japan Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 Australia Market
  • 11.24 Australia Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Australia Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 Indonesia Market
  • 11.28 Indonesia Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 Indonesia Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 South Korea Market
  • 11.32 Summary
  • 11.33 Market Overview
    • 11.33.1 Country Information
    • 11.33.2 Market Information
    • 11.33.3 Background Information
    • 11.33.4 Government Initiatives
    • 11.33.5 Regulations
    • 11.33.6 Regulatory Bodies
    • 11.33.7 Major Associations
    • 11.33.8 Taxes Levied
    • 11.33.9 Corporate Tax Structure
    • 11.33.10 Major Companies
  • 11.34 South Korea Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 South Korea Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 UK Market
  • 12.7 UK Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.8 UK Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 Germany Market
  • 12.11 Germany Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.12 Germany Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 France Market
  • 12.15 France Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.16 France Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 Italy Market
  • 12.19 Italy Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.20 Italy Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Spain Market
  • 12.23 Spain Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.24 Spain Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major companies
  • 13.3 Eastern Europe Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Russia Market
  • 13.7 Russia Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.8 Russia Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.10 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Clinical Decision Support Systems Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Investments
    • 14.15.11 Major Companies
  • 14.16 Canada Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulation
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 South America Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Clinical Decision Support Systems Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Africa Clinical Decision Support Systems Market, Segmentation By Component, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Clinical Decision Support Systems Market, Segmentation By Model, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Clinical Decision Support Systems Market, Segmentation By Delivery Mode, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Epic Systems Corporation
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Financial Overview
  • 18.3 Oracle Corporation
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Medical Information Technology, Inc. (Meditech)
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Financial Overview
  • 18.5 UnitedHealth Group. (Change Healthcare Inc.)
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Financial Overview
  • 18.6 Athenahealth Inc.
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Siemens Healthineers GmbH
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Wolters Kluwer N.V.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Altera Digital Health
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 MEDHOST
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 TruBridge
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 McKesson Corporation
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Koninklijke Philips N.V. (Royal Philips)
    • 19.7.1 Company Overview
    • 19.7.2 products And Services
  • 19.8 International Business Machines Corporation (IBM Watson Health)
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 GE Healthcare Technologies, Inc.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Allscripts Healthcare Solutions Inc.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Zynx Health Inc.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 Carestream Health Inc
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 NextGen Healthcare Inc.
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Agfa-Gevaert N.V. (Agfa)
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 VisualDx
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 AirStrip Technologies Acquired DECISIO Health
  • 22.2 VitalHub Acquired MedCurrent Corporation
  • 22.3 Beckman Coulter Diagnostics Acquired StoCastic
  • 22.4 Dedalus Group Acquired ExpertDoc
  • 22.5 Amalgam Acquired Avhana Health

23 Recent Developments In The Clinical Decision Support Systems market

  • 23.1 Establishing AI Advisory Councils For Ethical Clinical Decision Support
  • 23.2 Enhancing Medical Decision-Making Through AI And Large Language Models
  • 23.3 Revolutionizing Point-Of-Care Decision-Making With AI

24 Opportunities And Strategies

  • 24.1 Global Clinical Decision Support Systems Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Global Clinical Decision Support Systems Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Global Clinical Decision Support Systems Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Clinical Decision Support Systems Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer